series-a
Stage
2
Investors
About
Kala Bio develops novel therapies using engineered viruses to deliver nucleic acid medicines for treating genetic diseases.
Explore KALA BIO's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.